Canine Osteoarthritis

A practical veterinary reference on recognising, diagnosing and managing osteoarthritis in dogs using an individualised, multimodal and regularly reassessed plan.

Veterinary Clinical Reference

Species Dogs Category Orthopaedics Reading time 7 min Last reviewed August 4, 2026 Editorial author VetCalc Clinical Editorial Team Evidence Guideline- and consensus-informed draft
Clinical summary

A practical veterinary reference on recognising, diagnosing and managing osteoarthritis in dogs using an individualised, multimodal and regularly reassessed plan.

Overview

Canine osteoarthritis is a progressive disorder of synovial joints characterised by structural deterioration, pain, altered movement and declining function. It may arise from developmental disease, previous trauma, joint instability, abnormal conformation or cumulative mechanical stress. Although cartilage loss is a familiar feature, osteoarthritis should not be viewed as a cartilage-only problem. Synovium, subchondral bone, periarticular tissues, muscle, sensory pathways and behaviour all contribute to the clinical picture.

The practical aim of management is not simply to suppress lameness for a short period. It is to preserve comfortable movement, participation in normal activities, sleep, social interaction and quality of life while reducing avoidable adverse effects. Because chronic pain changes over time, an apparently stable patient still benefits from planned reassessment. Treatment commonly needs adjustment as disease, body weight, activity, concurrent illness and caregiver capacity change.

Clinical significance

Osteoarthritis is common, frequently under-recognised and not limited to elderly dogs. Young and middle-aged dogs with hip dysplasia, elbow dysplasia, patellar instability, cranial cruciate disease or previous joint injury may develop clinically important pain long before obvious radiographic change is discussed with the owner. Conversely, radiographic severity and observed disability do not always match. Clinical decisions should therefore integrate history, examination, functional assessment and the individual dog’s response to a carefully monitored plan.

Chronic pain can reduce activity and contribute to muscle loss, weight gain, poor sleep, reluctance to exercise and reduced interaction. These changes may be misinterpreted as ageing, stubbornness or loss of training. Early recognition is valuable because weight control, suitable activity and management of an underlying orthopaedic problem may slow the cycle of pain, inactivity and deconditioning.

Aetiology and risk factors

Primary osteoarthritis without an identifiable initiating abnormality is considered less common in dogs than secondary disease. Important contributors include developmental joint disease, ligament injury, fracture involving a joint, luxation, previous surgery, repetitive high-impact activity and chronic instability. Large body size and rapid growth may increase the consequences of developmental disease, while obesity increases mechanical load and may also promote a pro-inflammatory metabolic environment.

Risk assessment should include breed and conformation, age, body condition, activity history, previous lameness, known orthopaedic diagnoses, trauma and occupational demands. A dog may have more than one painful joint, and spinal, neurologic or soft-tissue disease may coexist. Management becomes more effective when the clinician identifies the dominant pain generators rather than assuming every mobility problem is caused by a single radiographic lesion.

Clinical presentation

Common signs include stiffness after rest, reduced willingness to climb stairs or jump, slowing on walks, shortened stride, difficulty rising, altered posture, intermittent or persistent lameness and reduced play. Owners may notice hesitation on slippery floors, changed sleeping locations, irritability when handled, reduced grooming or less enthusiasm for routine interactions. Signs can fluctuate with activity, weather, minor injury and medication adherence.

History-taking should focus on function in the home as well as performance during a brief clinic examination. Videos of rising, walking, turning, climbing and moving on different surfaces can be useful. Validated owner-completed instruments and structured pain or mobility questionnaires improve consistency and may reveal changes that are difficult to detect from memory alone.

Diagnostic approach

Diagnosis begins with a complete clinical history and physical examination. Observe the dog before handling, including posture, symmetry, weight shifting, transitions and gait. Orthopaedic examination should assess joint range of motion, effusion, crepitus, instability, muscle symmetry and pain response. A neurologic screen is important when weakness, ataxia, proprioceptive deficits or spinal pain are possible.

Radiography can support diagnosis, identify developmental or traumatic disease and help plan treatment, but imaging findings must be interpreted alongside clinical signs. Sedation may improve positioning and patient comfort. Advanced imaging, arthrocentesis or specialist assessment may be appropriate when findings are atypical, rapidly progressive, inflammatory, neurologic or poorly localised. Baseline laboratory testing is often considered before long-term medication, particularly in older dogs or patients with concurrent disease.

Differential diagnoses

Differentials depend on the affected region and presentation. They may include cranial cruciate ligament disease, meniscal injury, fracture, luxation, immune-mediated polyarthritis, septic arthritis, neoplasia, muscle or tendon injury, intervertebral disc disease, lumbosacral disease and peripheral neuropathy. Bilateral disease may reduce visible asymmetry and present mainly as slowing, stiffness or reluctance to exercise.

Red flags for reconsidering a routine osteoarthritis diagnosis include fever, marked joint swelling, severe pain disproportionate to previous signs, acute neurologic deficits, unexplained systemic illness, rapid deterioration, unusual radiographic destruction or failure to improve despite an appropriate trial of management.

Treatment and management

Management is usually multimodal. Core components commonly include weight optimisation, an appropriate exercise plan, environmental modification and analgesic therapy selected for the individual patient. The plan should be realistic for the household and should define how response and adverse effects will be monitored.

Weight reduction in an overweight dog can meaningfully improve mobility and may reduce medication requirements. Nutritional planning should use measured intake and regular body-weight and body-condition review rather than vague instructions to feed less. Exercise is generally controlled and consistent, avoiding repeated cycles of inactivity followed by intense activity. Low-impact walking, targeted strengthening and rehabilitation may improve function and confidence. Slippery flooring, difficult stairs, high vehicle access and unsuitable bedding can be modified with rugs, ramps, steps, supportive beds and strategically placed resources.

Non-steroidal anti-inflammatory drugs are commonly used where appropriate, but selection, baseline assessment, concurrent medication review and monitoring matter. Owners should receive clear instructions about adverse signs and should not combine veterinary NSAIDs with human analgesics or additional anti-inflammatory drugs unless specifically directed. Other analgesic approaches, rehabilitation, therapeutic exercise, adjunctive interventions and surgical treatment may be considered according to disease stage, evidence, patient factors and response. No single intervention should be expected to replace reassessment and a coherent overall plan.

Monitoring and follow-up

Monitoring should measure function, comfort and tolerability. Agree on two or three activities that matter to the dog and caregiver, such as rising without assistance, completing a defined walk, using stairs or sleeping comfortably. Repeat the same questionnaire or scoring system where possible. Recheck body weight, body condition, muscle condition, gait, joint findings, medication adherence and any adverse effects.

Early follow-up is useful after starting or changing treatment, followed by intervals based on stability and risk. Laboratory monitoring may be indicated for long-term medication. A sudden decline should prompt examination rather than automatic dose escalation because injury, cruciate disease, neurologic disease, infection or another painful condition may have developed.

Prognosis

Osteoarthritis is generally managed rather than cured. Prognosis for maintaining acceptable quality of life can be good when pain is recognised early, contributing disease is addressed, body weight is controlled and management is adjusted over time. Prognosis is more guarded when there is severe joint instability, multiple affected joints, advanced deconditioning, major obesity, important comorbidity or limited ability to implement the plan.

Progress should be judged by meaningful daily function rather than radiographic appearance alone. Periodic discussion of goals helps the veterinary team and caregiver recognise both improvement and unacceptable decline.

Prevention

Not all osteoarthritis is preventable. Risk reduction includes responsible breeding for relevant developmental disease, appropriate growth and nutrition, maintenance of lean body condition, sensible conditioning, prompt evaluation of persistent lameness and appropriate management of joint injury or instability. Exercise should match the dog’s age, conformation, health and conditioning rather than relying on occasional high-intensity sessions.

Key clinical points

  • Assess pain and function using history, observation and repeatable owner-reported measures.
  • Interpret imaging in the context of the patient; radiographic change and disability may not correlate closely.
  • Use an individualised multimodal plan rather than relying on a single treatment.
  • Weight optimisation, suitable activity and home modification are active treatments.
  • Reassess regularly and investigate unexpected deterioration.

Related calculators

Useful VetCalc tools may include the Liverpool Osteoarthritis in Dogs Score, canine pain assessment instruments, body-condition scoring and weight-management calculators. Calculator outputs support structured assessment but do not replace examination or clinical judgement.

References

  1. Gruen ME, Lascelles BDX, Colleran E, et al. 2022 AAHA Pain Management Guidelines for Dogs and Cats.
  2. Cachon T, Frykman O, Innes JF, et al. COAST Development Group international consensus guidelines for treatment of canine osteoarthritis.
  3. Mosley C, et al. Proposed Canadian consensus guidelines on osteoarthritis treatment in dogs.
  4. Guidelines for safe and effective use of non-steroidal anti-inflammatory drugs in dogs.

Editorial status: This is a guideline-informed draft for veterinary editorial review before publication. It does not provide patient-specific prescribing instructions.

References

  1. 2022 AAHA Pain Management Guidelines for Dogs and Cats: https://www.aaha.org/resources/2022-aaha-pain-management-guidelines-for-dogs-and-cats/
  2. COAST Development Group international consensus guidelines for treatment of canine osteoarthritis: https://pubmed.ncbi.nlm.nih.gov/37601753/
  3. Proposed Canadian consensus guidelines on osteoarthritis treatment in dogs: https://pubmed.ncbi.nlm.nih.gov/35558892/
  4. Guidelines for safe and effective use of NSAIDs in dogs: https://pubmed.ncbi.nlm.nih.gov/16299670/
Clinical context

Clinical context

Review & governance
Evidence: Guideline- and consensus-informed draft · Reviewed: 2026-08-04
Related tools
liverpool-osteoarthritis-in-dogs-score, canine-brief-pain-inventory, dog-body-condition-score
VetCalc Clinical Authority

Clinical authority & provenance

60%
Reviewed by VetCalc Clinical Team
Last reviewed 2026-08-04
Review due 4 Aug 2027
Evidence Guideline- and consensus-informed draft
Reading time 7 min
Clinical references 4

Authority indicators describe the completeness of VetCalc's own clinical metadata and references. They are not a substitute for independent clinical judgement or validated source material.